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Background: Although prescriptions are dispensed at discretion of medical professionals, many 
pharmaceutical companies use direct-to-consumer (DTC) advertising to increase sales. Over-
the-counter (OTC) medications are similarly marketed. 
Methods: We examined the content of advertisements in 38 issues of 9 popular US women’s 
fashion magazines. We evaluated target audience, health condition, product availability, 
message appeal, target to females, and mention of potential side effects and benefits.
Results: Sixty total medication advertisements were identified, 58.3% (95% CI: 45.8, 70.8) for 
prescription products. In magazines targeted to non-Hispanic Whites, >65% of advertisements 
were for OTC medications whereas 80% (95% CI: 66.7, 94.5) of advertisements found in 
Black/Latina magazines were for prescription medications. The rational appeal was used most 
commonly in non-Hispanic White magazines (75.9%; 95% CI: 60.3, 91.5). Emotional appeal 
was featured more often in prescription advertisements magazines (60.0; 95% CI:43.8, 76.2) 
compared to OTC (8.0; 95% CI: -2.6, 18.6).
Conclusion: Although emotional appeal may be effective for selling medication to women, it 
often does not completely inform consumers of potential risks.
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Introduction
The average person living in the United States sees 360 
advertisements each day through television, radio, inter-
net, newspapers, and magazines.1 Included in this high 
volume of product advertisement are targeted strategies 
to persuade consumers to purchase both over-the-counter 
(OTC) and prescription medications. Unlike the purchase 
of OTC products, consumers are not the final decision 
makers when it comes to prescription medications.2 The 
ultimate choice of which medication is prescribed lies with 
the physicians. Traditionally, prescription medication has 
been marketed exclusively to prescribing physicians and 
pharmacists. To more actively involve the consumer in the 
choice of prescription medication and to augment sales 
by increasing consumer demand, most pharmaceutical 
companies now utilize direct-to-consumer advertising 
(DCTA).3
The US Congress has supported several initiatives in 
an effort to protect consumers with regard to DTCA. Be-
fore the regulation of print advertisements, broadcasted 
promotional advertisements for prescription medications 
were required to include the drug’s chemical and brand 
names, drug indication, and potential side effects.4 Fur-
thermore, in 1997 the US Food and Drug Administration 
(FDA) released guidelines that held prescription medi-
cation advertisements targeted to both consumers and 
physicians to the same standards.5 These federal revisions 
allowed pharmaceutical companies to forgo inclusion of 
certain information in media advertisements by direct-
ing consumers to a physician, website, toll-free telephone 
number, or full print advertisement, which adversely may 
have contributed to an increase in DTCA in broadcast 
media (e.g. TV, radio).6 The legislation on print adver-
tisements for prescription medications has remained un-
changed since then and requires a brief summary contain-
ing information on who should not take the drug, when 
the drug should not be taken, possible serious side effects, 
and what can be done to lower the chances of side effects 
as well as less serious and frequently occurring side ef-
fects.7 Over-the -counter medication advertising (OTCA), 
HPP
Mongiovi et al
          Health Promot Perspect, 2017, Volume 7, Issue 1 29
regulated by the Federal Trade Commission, fall under 
different standards that require prior substantiation that 
an objective claim in the advertisement is true and that the 
advertisement is not misleading through misrepresenta-
tion or omitted information. Further, consumers must be 
informed about how to avoid harm, or how the benefit of 
the OTC medication outweighs consumer harm.8
Women specifically are often targeted by pharmaceu-
tical companies and have been found to be more easily 
persuaded, accepting of claims made in advertisements, 
and trusting even after a trust-violation in comparison 
to men.9,10 Advertisements targeting emotions may have 
greater appeal to women and research literature suggests 
that women are more conscious of their emotions than 
men, putting greater value on their feelings.11 Emotional 
appeal can be used in advertising to establish perceived 
benefit of a medication without necessarily including the 
health benefit and risk information, resulting in a more 
positive perceived benefit of the product or brand.12 
Women may also be a more profitable audience to market 
to since they are diagnosed with depression and anxiety at 
twice the rate as men and are more likely to have a chron-
ic condition that requires medical attention.13 These fac-
tors in combination with the established fact that women 
use more prescription medications in a month than men 
make women a prime population to be targeted by DTCA 
and OTCA.14
Opinions on medication advertisements vary among 
marketing strategists, pharmaceutical companies, con-
sumers and their prescribing physicians depending on 
whether the goal is monetary or health-oriented. Cur-
rently, the United States and New Zealand are the only 
countries that legally permit DTCA.15,16 Many consumers 
believe that DTCA is a resource that aids them in taking a 
more active role in their health care and help initiate con-
versations with doctors.2 So persuasive is DCTA that the 
majority of individuals who requested a medication from 
their doctor after having seen a prescription medication 
advertisement were given a prescription for that drug.17 
Doctors, however, have often claimed that the advertised 
medication requested was not the most effective for a par-
ticular patient and report that DTCA encourages individ-
uals to seek unnecessary treatment.18 These actions may 
be contributing to both over-diagnosis of conditions and 
over-prescribing of medications.18,19 The requested med-
ications are often more expensive than alternative treat-
ments since these products are marketed for profit and 
may not be covered under insurance.20 On the contrary, 
some studies have found that DTCA can trigger an indi-
vidual to seek out medical help when they typically would 
not have.21,22
The influence of OTCA on consumers has been over-
looked since intake of these medications is often con-
sidered minimal, normal, and does not require the rec-
ommendation and monitoring of intake by a health care 
professional.23 Prior studies have determined that unlike 
DTCA, OTCA has featured more content regarding the 
benefits of a particular products than the risk, omitting 
potentially dangerous health consequences,24 an observa-
tion confirmed in our analysis. Overall, less information 
is presented through OTCA than DTCA, even though the 
targeted consumers are the final decision makers for pur-
chasing these medications.2 Few have hypothesized on the 
decision-making process of consumers, resulting in limit-
ed information on consumer attitudes advertisements and 
the overall impact of OTCA.2,23
The purpose of this study was to both enumerate and 
assess the DTCA and OTCA in women’s fashion maga-
zines. Specifically, this study addressed differences found 
in magazines marketed to non-Hispanic White, Black, or 
Latina women and assessed the presence of marketing 
appeals, products marketed specifically to women, and 
legally required content for advertisement of prescription 
and OTC medications. Information learned from this in-
vestigation will provide insight into the content and style 
of advertisements found in women’s magazines that po-
tentially influence women’s decisions to seek out various 
medications.
Materials and Methods
US women’s fashion magazines were selected for this anal-
ysis because of the high readership among women aged 27 
to 46. This group of women are more likely to have spous-
es and children that they make medical decisions for, rep-
resenting the same audience targeted by manufacturers 
of pharmaceutical and OTC drugs.25,26 The choice of the 
individual fashion magazines reviewed was based on the 
readership characteristics publicized by each magazine in 
their on-line media kits, indicating a high level of reader-
ship within the targeted age range. A total of 99 issues of 
14 popular US women’s fashion magazines were reviewed 
for medication advertisements.27-37 The selected issues 
were published between January and August, 2014. Mag-
azines were grouped as those marketed predominantly to 
non-Hispanic White and those marketed to the African 
American and Latina audiences. The majority of maga-
zines targeted a non-Hispanic white women (Allure, Cos-
mopolitan, Elle, Girl’s Life, Glamour, Marie Claire, Seven-
teen, Teen Vogue, Vogue) and five of these magazines were 
marketed specifically to a Black or Latina audience (Cos-
mo Latina, Ebony, Essence, Jet, Latina). All pages in each 
magazine were examined for medication advertisements. 
A coding sheet was adapted from previous magazine 
analyses.38,39 Advertisements included were paid adver-
tisements (versus products deemed “Editor’s Picks” or 
featured in editorials/articles) for any medication (pre-
scription or OTC). Product advertisements placed on the 
magazine’s back cover (but not the front) were included. 
These advertisements were categorized on type of product 
advertised and those that featured either prescription or 
OTC medications were included in analysis. Advertise-
ments related to weight loss, dietary supplements, and 
vitamins were not included in the current study as these 
products are considered more similar to special foods.40 A 
total of 60 advertisements were found in 38 issues from 9 
different magazines (Allure, Cosmopolitan, Ebony, Essense, 
Glamour, Latina, Jet, Marie Claire, and Vogue). Medica-
tion advertisements were not found in magazines with a 
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median readership age less than 32 years. 
Advertisements were categorized by health condition,25 
as well as if the medication was available by prescription 
or OTC. Health conditions addressed in advertisements 
included mental health (depression, nerves), chronic dis-
ease management (asthma, cholesterol, diabetes, hepatitis 
C, high blood pressure, multiple sclerosis),41 acute con-
ditions (allergies, heartburn, headache/migraine, pain), 
cold/cough, birth control, physical appearance enhance-
ment (facial injections, eyelash extensions, acne) and 
vaccines. 
The content and message appeal of each advertisement 
was also determined. Potential message appeals includ-
ed emotional (showing happiness or peace of mind) and 
rational appeals (providing information).42 Whether the 
producted advertised was being marketed as exclusively 
for women was also determined. Lastly, the presence or 
absence of clear documentation stating the potential side 
effects and benefits of the advertised prescription and 
OTC medication was assessed. The kappa for inter-rater 
reliability of these classifications was determined to be 
87.0%, which was determined by recoding 10% of all mag-
azines selected by random number generation. 
We conducted descriptive analyses that included testing 
for associations between content and either intended au-
dience (non-Hispanic White vs. Black/Latina) or product 
availability (prescription vs. OTC) using chi-square analy-
sis. All analyses were performed using IBM SPSS (version 
22). The institutional review boards at William Paterson 
University, Teachers College, Columbia University, and 
Lehman College do not review studies that do not involve 
human subjects research.
Results
A total of 60 medication advertisements from nine pop-
ular US fashion magazines marketed to women were 
assessed (Table 1). The number of medication adver-
tisements found in a given magazine ranged from 1 to 
4, with a median of 1 advertisement (standard deviation 
[SD] = 0.78). Over 50% (51.7%; 95% CI: 39.1, 64.3) of ad-
vertisements appeared in magazines targeted to an eth-
nic audience (Blacks and Latinas) (51.7%; 95% CI: 39.1, 
64.3). Overall, most advertisements were for prescription 
medications (58.3%; 95% CI: 45.8, 70.8) but differed sig-
nificantly by the type of audience to which the product 
was marketed to. Nearly all of the advertisements found 
in Black and Latina magazines were for prescription drugs 
(80.6%; 95% CI: 66.7, 94.5) whereas 65.5% (95% CI: 48.2, 
82.8) of advertisements in magazines targeted to non-His-
panic White women were for OTC products (P < 0.0001). 
In this sample, the most common health conditions 
address in advertisements were for cold/cough (23.3%; 
95% CI: 12.6, 34.0) and mental health (18.3%; 95% CI: 
8.5, 28.1) (Table 1). Advertisements in magazines mar-
keted to non-Hispanic White women followed a similar 
trend: cold/cough (37.9%; 95% CI: 20.2, 55.6), physical 
appearance enhancement (27.6%; 95% CI: 11.3, 43.4), and 
mental health (17.2%; 95% CI: 3.5, 30.9) medications. Sig-
nificant differences were found in magazines marketed to 
Black or Latina women vs. those targeting non-Hispanic 
White women: the most common advertisements in mag-
azines for Black or Latina women were for chronic dis-
ease management (25.8%; 95% CI: 10.4, 41.2), followed by 
birth control (22.6%; 95% CI: 7.9, 37.3) and mental health 
(19.4%; 95% CI: 5.48, 33.3) medications (P < 0.0001). 
The majority of advertisements used a rational mes-
sage appeal to attract consumers (63.3%; 95% CI: 51.1, 
75.5) (Table 1). Medication advertising that appealed 
to the emotions was observed more often in magazines 
targeting Black and Latina women (54.8%; 95% CI: 37.3, 
72.3) compared to magazines geared toward non-Hispan-
ic White women (20.7%; 95% CI: 6.0, 35.5) (P = 0.007). 
Findings suggest that advertisements in magazines tar-
geted to non-Hispanic White women use more rational 
Table 1. Characteristics of magazine sample advertisements by targeted audience (n = 60)
Total 
No. (%) (95% CI)
Non-Hispanic White 
No. (%) (95% CI)
Black/Latina 
No. (%) (95% CI)
P value
29 (48.3) (35.7, 60.9) 31 (51.7) (39.1, 64.3)
Availability of medication <0.0001
 Prescription required 35 (58.3) (45.8, 70.8) 10 (34.5) (17.2, 51.8) 25 (80.6) (66.7, 94.5)
 Over the counter 25 (41.7) (29.2, 54.2) 19 (65.5) (48.2, 82.8) 6 (19.4) (5.5, 33.3) 
Health condition <0.0001
 Mental health 11 (18.3) (8.5, 28.1) 5 (17.2) (3.5, 30.9) 6 (19.4) (5.48, 33.3)
 Chronic disease management 9 (15.0) (6.9, 24.0) 1 (3.4) (-3.2, 10.0) 8 (25.8) (10.4, 41.2)
 Acute conditions 9 (15.0) (6.9, 24.0) 4 (13.8) (1.3, 26.4) 5 (15.1) (2.5, 27.7)
 Cold/cough 14 (23.3) (12.6, 34.0) 11 (37.9) (20.2, 55.6) 3 (9.7) (-0.7, 20.1)
 Birth control 7 (11.7) (3.6, 19.8) 0 (0.0)- 7 (22.6) (7.9, 37.3)
 Physical appearance enhancement 8 (13.3) (4.7, 21.9) 8 (27.6) (11.3, 43.4) 0 (0.0)-
 Vaccines 2 (3.3) (-1.2, 7.8) 0 (0.0)- 2 (6.5) (-2.2, 15.2)
Marketing appeala
 Emotional appeal 23 (38.3) (26.0, 50.6) 6 (20.7) (6.0, 35.5) 17 (54.8) (37.3, 72.3) 0.007
 Rational appeal 38 (63.3) (51.1, 75.5) 22 (75.9) (60.3, 91.5) 16 (51.6) (34.0, 69.2) 0.051
a Groups not mutually exclusive.
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appeal (75.9%; 95% CI: 60.3, 91.5) compared to those in 
magazines for Black and Latina women (51.6%; 95% CI: 
34.0, 69.2).
In comparing prescription medication advertisements 
to OTC, the emotional appeal was featured more often in 
advertisements for medications that required a prescrip-
tion (60.0; 95% CI: 43.8, 76.2) than those that did not 
(8.0; 95% CI: -2.6, 18.6) (Table 2). Rational appeal was 
used in nearly all advertisements for OTC medications 
(92.0%; 95% CI: 81.4, 102.6) compared to less than half of 
advertisements for prescription medications (42.9%; 95% 
CI: 26.5, 59.3) (P < 0.0001). Almost all advertisements 
contained information on the benefits (96.7%; 95% CI: 
92.2,101.2) and possible side effects (93.3%; 95% CI: 87.0, 
99.6) of the medication advertised. OTCA (16.0%; 95% 
CI: 1.6, 30.4) was more likely than DTCA to omit poten-
tial side effects (0%; P = 0.014). OTC medication adver-
tisements were also less likely to be marketed exclusively 
for women (12.0%; 95% CI: -0.7, 24.7) than prescription 
medications (48.6%; 95% CI: 32.0, 65.2) (P = 0.003).
Discussion
The majority of medications advertised to women were for 
products only available with a prescription. More DTCA 
was featured in magazines targeted to Black/Latina wom-
en than magazines targeting non-Hispanic White women. 
This may be explained by the greater number of advertise-
ments for chronic disease management and birth control 
found in these magazines. Compared to magazines sold to 
Black or Latina women, magazines marketed to non-His-
panic White women contained significantly more adver-
tisements for cold/cough medications and products for 
changing physical appearance, many of which are available 
OTC. Of particular interest were the differences in mar-
keting appeals used in advertisements targeted to women 
of different ethnicities. Emotional appeal was more than 
twice as likely to be used in advertisements found in Black 
or Latina magazines while rational appeal was used 50% 
more frequently in non-Hispanic White magazines. 
Similar to the findings of others,43 the greatest number 
of medication advertisements in our sample was found in 
magazines targeted to Black women. Research indicates 
that magazines targeted to Black women less often contain 
advertisements for joint pain and high cholesterol, how-
ever, over 25% of the advertisements found in magazines 
aimed at the ethnic market were for chronic disease man-
agement. The only advertisements found in magazines 
marketed specifically to Latina women were for acute 
conditions and cold/cough, which is consistent with find-
ings demonstrating that Hispanic Americans use consid-
erably fewer prescription products overall than non-His-
panic White Americans, regardless of health conditions.44 
Given this lack of expenditure and that Hispanic Ameri-
cans are the largest minority group in the United States, 
there currently exists a large, underutilized audience that 
companies may look to target.45 This is of particular con-
cern since research has found that Hispanic Americans 
rely more on DTC advertising than non-Hispanic White 
Americans and are less skeptical of claims.46
This study was limited by the number of advertisements 
used in analysis. This limited sample size still reflected the 
audience targeted by manufacturers of pharmaceutical 
and OTC products based on age range. The convenience 
sampling strategy may have introduced selection biased 
based on availability of magazines. However, regardless of 
where the issues were purchased, the magazines marketed 
to non-Hispanic white, Black, and Latina women, respec-
tively, had the highest circulation of fashion magazines 
in the United States within their targeted demographic 
group. Future studies should include magazines of various 
genres specifically targeted to women in order to improve 
sample size and to limit this potential bias.
Conclusion
The present study found that women of different ethnic 
backgrounds are not targeted similarly by pharmaceutical 
companies through advertisements in women’s fashion 
magazines. While health conditions may vary between 
ethnic groups, differences still exist in message appeals 
and product availability. Black or Latina women are more 
Table 2. Advertisement content by prescription requirement (n = 60)
Total  
 No. (%)





35 (58.3) (45.8, 70.8) 25 (41.7) (29.2, 54.2)
Marketing appeala
 Emotional appeal 23 (38.3) (26.0, 50.6) 21 (60.0) (43.8, 76.2) 2 (8.0) (-2.6, 18.6) <0.0001
 Rational appeal 38 (63.3) (51.1, 75.5) 15 (42.9) (26.5, 59.3) 23 (92.0) (81.4, 102.6) <0.0001
Product exclusively for women 0.003
 Yes 20 (33.3) (21.4, 45.2) 17 (48.6) (32.0, 65.2) 3 (12.0) (-0.7, 24.7)
 No 40 (66.7) (54.8, 78.6) 18 (51.4) (34.8, 68.0) 22 (88.0) (75.3, 100.7)
Possible side effects 0.014 
 Yes 56 (93.3) (87.0, 99.6) 35 (100.0) - 21 (84.0) (69.6, 98.4)
 No 4 (6.7) (0.4, 13.0) 0 (0.0) - 4 (16.0) (1.6, 30.4)
Benefits described 0.808
 Yes 58 (96.7) (92.2,101.2) 34 (97.1) (91.5, 102.7) 24 (96.0) (88.3, 103.7)
 No 2 (3.3) (-1.2, 7.8) 1 (2.9) (-2.7, 8.5) 1 (4.0) (-3.7, 11.7)
Abbreviation: Over-the-counter.
a Groups not mutually exclusive.
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likely to be targeted by pharmaceutical companies through 
emotional appeal than non-Hispanic White women. Ad-
ditionally, prescription drugs were advertised mainly with 
emotional appeal while OTC medications featured ratio-
nal appeal. Although this type of appeal may be effective 
for selling a product, it often does not completely inform 
consumers of potential risks. Future studies should ex-
pand on the differences to better understand the influ-
ence of both DTCA and OTCA on women. Additionally, 
further research should be done to evaluate the attitudes 
of consumers towards claims made in advertisements, es-
pecially those for medications that are not regulated by 
medical professionals. Understanding the influence of 
these types of advertisements on potential consumers can 
promote conversations between health care workers and 
patients to better understand possible risks. 
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